Enlivex Therapeutics Ltd.
ENLV
Revenue
0.00
0.000.00%
-Assets
27.69M
▼-4.22M▼-13.21%
6 Months ChangeLiabilities
4.10M
▲758.00k▲22.69%
6 Months ChangeFree Cash Flow
-13.11M
▲10.65M▲44.82%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-04-30
Form 20-F
ID: 0001213900-24-037878
2023-04-10
Form 20-F
ID: 0001213900-23-028398
2022-04-29
Form 20-F
ID: 0001213900-22-022527
2021-04-30
Form 20-F
ID: 0001213900-21-023865
2020-04-30
Form 20-F
ID: 0001213900-20-010632
2019-04-30
Form 20-F
ID: 0001213900-19-007437
2018-04-23
Form 20-F
ID: 0001144204-18-021827
2017-02-24
Form 20-F
ID: 0001144204-17-011029
2016-03-29
Form 20-F
ID: 0001144204-16-090954
2015-03-31
Form 20-F
ID: 0001144204-15-019667